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Abstract--The effects of N-(n-butyl)-l,3-diaminopropane (BDAP) on cell growth and polyamine 
content were examined in L1210, SV-3T3 and HT-29 cells. In all cases, BDAP was a specific and highly 
effective inhibitor of spermine synthesis, and spermine levels were greatly suppressed in the presence 
of 50/LM BDAP. At the same time, there was a parallel increase in spermidine, which equalled or 
exceeded the fall in spermine so that total polyamine levels were not reduced. Cell growth was not 
affected in short-term experiments but culture of L1210 cells for 72-144 hr in the presence of BDAP 
did lead to an effect on growth that was reversed by the addition of spermine. These results suggest 
that, in the short term, a normal growth rate is maintained by spermidine but that a function or cellular 
component critically dependent on spermine becomes depleted at longer times. BDAP was a weak 
inducer of spermidine/spermine-Nl-acetyltransferase and this enzyme may be responsible for excretion 
or degradation of the inhibitor. The reduction of spermine produced by BDAP led to a substantial 
increase in the activity of S-adenosylmethionine decarboxylase (AdoMetDC) showing that the repression 
of this enzyme by spermine is greater than the repression by spermidine. Although higher concentrations 
were required, BDAP was as effective an inhibitor of spermine synthesis as the mechanism-based 
inhibitor, S-adenosyl-l,12-diamino-3-thio-9-azadodecane (AdoDATAD), and produced similar 
decreases in spermine and increases in AdoMetDC. Prior treatment of HT-29 human colon carcinoma 
cells with BDAP increased the killing by chloroethylating agents but to a much smaller extent than the 
increase brought about by the DNA repair inhibitor, O6-benzylguanine. The effect of BDAP is likely 
to be due to an increased interaction of chloroethylating drugs with nuclear DNA in the absence of 
spermine since BDAP treatment sensitized cells even in the presence of O6-benzylguanine, which 
prevents repair of these lesions. 
Polyamines are ubiquitous cellular components that 
may be necessary for a variety of cellular functions 
and are clearly essential for cell growth [ 14].  Specific 
inhibitors of enzymes in the polyamine biosynthetic 
pathway are useful for research into the functions 
of polyamines and are needed for distinguishing the 
importance of the individual polyamines, putrescine, 
spermidine and spermine. In addition, inhibitors 
of ornithine decarboxylase (ODC)§ and of S- 
adenosylmethionine decarboxylase (AdoMetDC) 
are useful therapeutic agents for a variety of diseases 
including trypanosomiasis and cancer [3-6]. Less 
attention has been given to inhibitors of the 
aminopropyltransferases capable of blocking either 
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spermidine synthase or spermine synthase although 
several potentially useful agents have been described 
[7-15]. These include S-adenosyl-l,8-diamino-3- 
thiooctane (AdoDATO) 17.9, 10], cyclohexylamine 
[8, 111 and trans-4-methylcyclohexylamine [11, 12] 
that inhibit spermidine synthase, and S-adenosyl- 
1,12-diamino-3-thio-9-azadodecane (AdoDATAD) 
[13, 14], N-(n-butyl)-l,3-diaminopropane (BDAP) 
[15] and N-(3-aminopropyl)cyclohexylamine [12] 
that have been reported to interfere with spermine 
synthase. 
There is a particular need for more information 
on the effects of inhibition of spermine synthesis. 
Although all mammalian cells and many lower 
eukaryotes contain a discrete spermine synthase and, 
therefore, have levels of spermine comparable to 
those of spermine, the physiological value of this 
enzyme is unclear. Many studies have shown that 
spermidine is needed for growth and spermidine is 
essential for continued protein synthesis by virtue of 
its role as a precursor of hypusine, a post-translational 
modification of initiation factor eIF-5A essential for 
its activity [3-6, 16, 17]. Spermidine can be replaced 
by spermine in many of its actions, and addition of 
spermine to cells whose growth is blocked by addition 
of inhibitors of ODC or AdoMetDC restores growth 
but spermine can give rise to spermidine by virtue 
of the spermidine/spermine-NI-acetyltransferase 
(SAT)/polyamine oxidase pathway. Although the 
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Fig. 1. Structures of BDAP and AdoDATAD. 
binding of the tetramine, spermine, to nucleic acids 
and presumably other cellular polyanions is stronger 
than that of the triamine, spermidine [18, 19], there 
are, at present, no known unique functions for 
spermine itself. Detailed, long-term studies with 
inhibitors of spermine synthase may be needed to 
answer this question. 
A number of polyamine analogs are also 
being considered as potential antineoplastic agents 
[3, 4, 20, 21]. Application of these compounds, of 
which NI,N12-bis(ethyl)spermine (BE-3-4-3) is an 
example, reduces further normal cellular content 
dramatically by repressing ODC and AdoMetDC,  
inducing SAT and causing the excretion of putrescine, 
spermidine and N-acetylated polyamines from the 
cell [20-24]. Loss of spermine is brought about by 
such analogs but occurs less readily since spermine 
itself is not excreted and its disposal appears to 
require the action of SAT [21,24]. Reduction of the 
initial spermine content may allow the analogs to be 
employed more effectively. 
In the experiments reported in this paper, we 
studied the effects of BDAP on polyamine levels 
and cell growth in a number of mammalian cell lines 
and compared its effects with those of A d o D A T A D .  
The structures of these compounds are shown in 
Fig. 1. 
We also examined the effects of BDAP-induced 
spermine depletion on the sensitivity of tumor cells 
to certain alkylating agents. It is known that depletion 
of putrescine and spermidine brought about by 
treatment with o:-difluoromethylornithine, an ODC 
inhibitor, renders cells more susceptible to killing 
by 1,3-bis(2-chloroethyl)-N-nitrosourea (BCNU) 
[25, 26]. Although the mechanism underlying this 
effect is not clear, it presumably relates to a change 
in the content or persistence of the lesions resulting 
from interaction of the alkylating agent with DNA. 
We used BDAP to determine whether depletion of 
spermine may produce a similar type of effect. 
MATERIALS AND METHODS 
Materials. S-Adenosyl-L-[carboxyJ4C]methionine 
(47.8 mCi/mmol) was purchased from NEN. [14C]- 
AcetyI-CoA (55 mCi/mmol) was obtained from ICN. 
A d o D A T A D  and BDAP were synthesized as 
described in Refs. 13 and 15, respectively. Polyamines 
and other biochemical reagents were obtained from 
Sigma. BE-3-4-3 was provided by Dr. R. J. Bergeron, 
Department of Medicinal Chemistry, University 
of Florida, Gainesville, FL. 1-(2-Chloroethyl)-3- 
cyclohexyl-l-nitrosourea (CCNU) (NSC 79037) 
and 2-chloroethyl (methylsulfonyl)methanesulfonate 
(Clomesone) (NSC 33847) were obtained from the 
Drug Synthesis and Chemistry Branch, Division of 
Cancer Treatment, National Cancer Institute, 
Bethesda, MD. 
Cell culture. The source of the cells and the culture 
conditions have been described previously for HT- 
29 cells [24], SV-3T3 cells [27, 28] and L1210 cells 
[17]. 
Enzyme assays. AdoMetDC was assayed by 
measuring the production of 14CO2 from S-adenosyl- 
L-[carboxyj4C]methionine [29, 30]. SATwasassayed 
by determining the conversion of [14C]acetyI-CoA 
into [14C]acetyl-spermidine as described [24]. 
Polyamine and BDAP analysis. Cells were 
harvested by centrifugation and washed twice with 
ice-cold phosphate-buffered saline. The washed cell 
pellet was resuspended in 10% (w/v) trichloroacetic 
acid, the protein precipitate was removed by 
centrifugation, and the supernatant was filtered 
(0.22~m) before reversed-phase HPLC analysis 
to separate BDAP, putrescine, spermidine, and 
spermine. Post-column derivatization with o-phthal- 
aldehyde and fluorescence detection was used to 
quantitate the polyamines [17]. Cell protein was 
measured by the method of Bradford [31]. Polyamine 
content was expressed per milligram of total cell 
protein. 
Effects of chloroethylating agents. The effects on 
killing by alkylating agents were determined 
by assaying either colony-forming efficiency or 
cytotoxicity as follows. Cell colony-forming efficiency 
after treatment with BDAP was determined by 
plating HT-29 cells at a density of 0.25 x 10 ~ cells/ 
25 cm 2 flask. Four hours later BDAP was added to 
some flasks, and after a further 92 hr, the medium 
was replaced with fresh medium containing various 
concentrations of either CCNU or Clomesone for 
2 hr at 37 °. The medium was then replaced with the 
same medium as that used for the pretreatment for 
an additional 18 hr, and the cells were re-plated at 
densities between 100 and 3200 per 25 cm 2 flask. 
The cells were allowed to grow for 10-12 days, and 
colonies were then washed with 0.9% saline, stained 
with 0.5% crystal violet in ethanol, and counted. 
Results were expressed as the percentage of colonies 
present when no chloroethylating agent was added. 
Cytotoxicity was evaluated using modifications of 
the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetra. 
zolium bromide (MTT) assay [32]. Cells were plated 
at a density of 500cells/well in 96-well plates, 
allowed to grow and treated with chloroethylating 
agents as described above. Five days after drug 
treatment, 25/JL of a 5 mg/mL solution of MTT was 
Inhibition of spermine synthase 
Table 1. Effect of BDAP on polyamines in human and rodent cells 
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Polyamine content (nmol/mg protein) 
Treatment and cells Putrescine Spermidine Spermine Total 
SV-3T3 48 hr 
SV-3T3 72 hr 
SV-3T3 + 50/aM BDAP, 48 hr 
SV-3T3 + 50/aM BDAP, 72 hr 
SV-3T3 + 50/aM BDAP, 72 hr + 
25/aM BE-3-4-3, 24 hr 
SV-3T3 + 25/aM BE-3-4-3, 24 hr 
HT-29, 48 hr 
HT-29, 72 hr 
HT-29 + 50 #M BDAP, 48 hr 
HT-29 + 50/aM BDAP, 72 hr 
HT-29 + 50/aM BDAP, 72 hr + 
25/aM BE-3-4-3, 24 hr 
HT-29 + 25/aM BE-3-4-3, 24 hr 
L1210, 48 hr 
L1210, 72 hr 
L1210 + 50/aM BDAP, 48hr 
L1210 + 50/aM BDAP, 72hr 
L1210 + 50/aM BDAP, 72hr + 
25/aM BE-3-4-3, 24 hr 
L1210 + 25/aM BE-3-4-3, 24 hr 
4 .0±0.2  27.8±0.4 14.0±0.9 45.8 
7.4±1.1 26.9±2.2 13.9±1.7 48.2 
0 .4±0.3  48.3±8.7 3.5±0.5 52.2 
0 .8±0.2  47.1±3.5 2 .4±0.2  50.3 
0 .4±0.3  6.4±0.5 1.5±0.1 8.3 
0.2±0.1 3.0±0.2 8 .7±0.4  11.9 
9 .0±2.2  16.7±3.1 24.2±3.5 49.9 
4 .4±1.2  12.0±2.1 22.4±4.2 38.8 
0 .7±0.2  43.3±6.1 5 .6±0.2  49.6 
0.2±0.1 37.7±2.8 5 .9±0.6  43.8 
<0.1 7.9±0.7 4.8±0.7 12.7 
<0.1 2 .8±0.4  11.3±1.0 14.1 
3 .0±0.4  20.1±2.1 9 .9±0.6  33.0 
1.9±0.4 24 . l±2 .5  9 .4±0.7  35.4 
0 .4±0.2  28.3±6.1 2 .1±0.2  30.8 
1.4±0.4 31.5±2.3 1.4±0.3 34.3 
<0.1 6.1 ±_ 0.1 1.2 -'- 0.1 7.3 
<0.1 2.6 ± 0.2 6.0 ± 0.2 8.6 
BDAP was added at 4 hr after plating and the cells were grown for the time shown. BE-3-4-3 
was added after 48 hr of culture and the cells were harvested 24 hr later. Results are the means - SD 
for at least 4 estimations. 
added to each well fol lowed 2 hr later by the addition 
of 100/~L lysing buffer,  pH 4.7 (20% sodium dodecyl 
sulfate, 50% N,N-dimethyl formamide  and 0.8% 
acetic acid) for an additional 22 hr. A microplate 
reader  set at 570nm was used to determine the 
absorbance. The number  of cells killed was then 
determined as the fraction of the optical density seen 
in the cells t reated with vehicle alone. 
R E S U L T S  
Depletion of spermine by BDAP. Addit ion of 
50 jaM B D A P  to the culture medium led to a marked 
depletion of  spermine (by about  80%) within 48-  
72hr  in several different mammal ian  cell lines, 
virally t ransformed mouse fibroblasts (SV-3T3), 
mouse leukemia cells (L1210) and human colon 
carcinoma cells (HT-29) (Table 1). At  the same 
time, there was an increase in cellular spermidine. 
This is consistent with B D A P  blocking the spermine 
synthase step of polyamine biosynthesis. Because of 
the compensatory increase in spermidine,  there was 
no decrease in total polyamine content.  This total 
remained the same in L1210 cells, increased slightly 
in SV-3T3, and increased to a greater  extent at 72 hr 
in HT-29 cells. Exposure  to B D A P  also markedly 
reduced the content  of  putrescine in all three cell 
lines (Table 1). Despi te  the large decrease in 
spermine,  there was no effect of B D A P  on growth 
of these cells over  the 72-hr period tested (results 
not shown). 
When cells were t reated with BE-3-4-3, there was 
a profound drop in the concentrat ions of all of the 
polyamines, al though spermine was affected to the 
i~I BDAP content (nrnot/rng) 
! Spermine content (nmol/mg) 
[ ]  AdoMetDC activity (units/rag) I 
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Fig. 2. Effect of BDAP on spermine and AdoMetDC in 
HT-29 cells. The HT-29 ceils were grown in the presence 
of 0, 50 or 100/aM BDAP for 48, 72 or 120 hr as indicated. 
The content of spermine and BDAP and the activity of 
AdoMetDC were then measured in extracts as described 
under Materials and Methods. Results are the means ± SD 
for at least 4 estimations. 
least extent (Table 1). The combinat ion of B D A P  
with BE-3-4-3 slightly increased the total extent  of  
polyamine depletion and markedly reduced cellular 
spermine but there was again a parallel increase in 
spermidine. 
A slightly greater effect on spermine levels (85% 
reduction) was achieved using 100/~M B D A P  rather 
than 50/~M in HT-29 cells for 48 hr (Fig. 2). The  
higher level of B D A P  was reflected in the intracellular 
B D A P  content  which almost doubled with the higher 
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Fig. 3. Spermine-mediated reversal of LI210 cell growth 
inhibition by BDAP. LI210 cells were seeded at a density 
of 10~cells/mL and allowed to grow for 72hr in the 
presence of 50 #M BDAP and/or 5 ¢tM spermine as shown. 
The cells were then re-seeded at the starting density in the 
same medium and grown for a further 72 hr. The procedure 
was then repeated for a third timc. All cultures contained 
1 mM aminoguanidine to prevent conversion of the added 
spermine to toxic oxidation products. 
dose. The reduction in spermine was not increased 
by further exposure to BDAP for up to 120 hr, and 
it appears that the effects may be slightly less by 
120 hr. At this time point, the reduction in spermine 
was only 50% with 501tM BDAP and 74% with 
100/xM. This may be due to the fact that the cellular 
content of BDAP actually fell slightly with time (Fig. 
2), and it is possible that the inhibitor was degraded 
or excreted. 
Effects o f  B D A P  on cell growth. Although in 
short-term experiments of up to 72-hr exposure, 
there was no effect of BDAP-mediated spermine 
depletion on cell growth, this may not be the case 
at longer times. In HT-29 cells treated for 120 hr, 
growth was reduced by 22% at 50 ~M BDAP and 
by 30% with 100pM (results not shown). 
Longer term effects on growth were, therefore, 
examined more fully in L1210 cells by re-seeding 
the treated cells into the medium containing 50/~M 
BDAP so that growth and effects on polyamines 
could be tested over a period of 220 hr. As shown 
in Fig. 3, an inhibitory effect on growth became 
apparent at times after 144 hr, and this effect was 
prevented completely by providing 5 #M spermine. 
Addition of 5 #M spermine to the culture medium 
also completely overcame the BDAP-mediated 
depletion of spermine in the cells at 72 hr (results 
not shown) and at 144 hr (Table 2). There was no 
change in the intracellular level of BDAP when 
spermine was added (Table 2), showing that the 
reversal of the effect on growth was not due to a 
change in uptake of the inhibitor, Similar experiments 
carried out with D-R cells (DFMO-resistant variants 
of L1210 that have 100 times higher ODC activities 
and much higher putrescine and slightly higher 
spermine contents when grown in the absence of 
DFMO [33]) showed exactly the same results (not 
shown). 
Induction of  sperrnidine/spermine NLacetyl - 
transferase (SAT) by BDAP. Many polyamine 
analogs have been shown to act as inducers of SAT. 
Since SAT activity is linked to the degradation of 
polyamines and their excretion from the cell, such 
induction can contribute significantly to the effects 
of such analogs on cellular polyamine content [21]. 
However, as shown in Table 3, BDAP was only 
weakly active in inducing SAT, giving a 3- to 4-fold 
increase as opposed to the more than 100-fold rise 
in activity produced by a powerful inducer such as 
BE-3-4-3 [20-24[. It is therefore unlikely that much 
of the effect of BDAP on polyamines is due to an 
increase in polyamine acetylation. However, the 
induction of SAT could play a role in the reduction 
of BDAP levels at prolonged incubation times (Fig. 
2), since BDAP is a weak substrate for SAT (Pegg 
AE and Albanese L, unpublished observations). 
Effect o f  B D A P  on AdoMetDC. Previous work 
has shown that the cellular activity of AdoMetDC 
is negatively affected by the polyamine content 
[29, 30, 34, 35 and references therein[. As shown in 
Fig. 2, the activity of AdoMetDC was increased 3- 
to 5-fold in HT-29 cells treated with BDAP. This 
increase correlated with the decline in spermine. 
Con~parison qf  BDAP with AdoDA TAD. Overall, 
the results described above are compatible with 
BDAP being a relatively specific inhibitor of 
spermine svnthase leading to an increase in 
spermidine because of its lack of conversion to 
spermine. These results suggest that BDAP, which 
is much easier to synthesize than AdoDATAD, may 
be as effective and specific as an inhibitor of spermine 
formation. Direct comparisons in L1210 and HT-29 
cells suggest that this is indeed the case (Table 4). 
The percentage changes in spermine, spermidine 
and AdoMetDC were indistinguishable when these 
inhibitors were compared. The only difference was 
in the content of putrescine, which was reduced 
more effectively by BDAP. 
E]fects of  BDAP on the susc~7~tibility of  HT-29 
cells to chloroethylating agents. It has been reported 
by Marton and colleagues [25, 261 that exposure of 
cells to inhibitors of ODC increases the sensitivity 
of some tumor cell lines to killing by chloroethy[ating 
drugs. The effect of depletion of spermine by BDAP 
and AdoDATAD on the sensitivity of HT-29 cells 
to these agents was tested by treating the cells for 
2hr  with either CCNU or Clomesone. After a 
further 18hr in the presence of the spermine- 
synthase inhibitors to allow for the conversion of 
the initial DNA adducts to interstrand cross-links, 
the cell killing was measured using either a colony- 
forming assay (Fig. 4) or a cytotoxicity assay (Fig. 
5). Two different assays were used to ensure that 
the results were not biased by the assay method. 
Using the colony-forming assay, it was found that 
BDAP did enhance killing of HT-29 cells by CCNU 
or by Clomesone and that this could be prevented 
by providing spermine (Fig. 4), A limited study with 
AdoDATAD also showed a similar enhancement of 
the effects of Clomesone (results not shown), but 
these experiments were limited by the small amount 
of drug available and the inhibition of cell plating 
by the drug itself. The cytotoxicity assays confirmed 
Inhibition of spermine synthase 
Table 2. Effect of BDAP and spermine on polyamines in LI210 cells 
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Treatment 
Polyamine content (nmol/mg protein) 
Putrescine Spermidine Spermine Total BDAP 
None, 144 hr 
50/~M BDAP, 144hr 
50 ~M BDAP + 
5 ~uM spermine, 144 hr 
2.7 +_ [1.5 22.9 + 3.2 1(}.9 ± 1.7 36.5 
1.4_+0.4 28.1 ±5.9 1.3±(I.3 30.8 
2~ ± 0.11 23.5 -+ 1.6 9.5 ± 1.9 35.4 
0.0 
7.9 _+ 1.7 
8.5 _+ 1.2 
Results are the means ±-- SD for at least 4 estimations. 
Table 3, Effect of BDAP on SAT in SV-3T3 cells 
SAT activity (units/mg protein) 
Treatment 48 hr 72 hr 
None 4.5 + 0.6 2.2 - 0.2 
50/~M BDAP 12.2 -+ 0.6 7.9 + 1.3 
25/~M BE-3-4-3 333 ± 47 548 - 33 
Activity was measured after exposure to the drugs for 
the time shown. Results are the means --+ SD for at least 
4 estimations. 
that there was an increased killing of BDAP- t rea ted  
cells (Fig. 5). 
HT-29 cells have a high content  of O6-alkylguanine - 
D N A  alkyltransferase which strongly protects 
against chloroethylat ing drugs by removing initial 
monoadducts  formed in D N A  before they rearrange 
to form lethal cross-links [36,37]. The alkyl- 
transferase activity can be depleted by use of O ~'- 
benzylguanine [33], and such deplet ion is known to 
have a very large effect on the killing of HT-29 cells 
by chloroethylating agents [38, 39]. Therefore ,  the 
possible interaction between O6-benzylguanine and 
B D A P  was tested. Trea tment  with O6-benzylguanine 
had the expected result, increasing cytotoxicity 
substantially (Fig. 5). B D A P  increased cell killing 
to a smaller extent but was effective in the presence 
or absence of O6-benzylguanine, suggesting that the 
effects of spermine depletion were not mediated by 
changes in D N A  repair during the period after 
t reatment  with the chloroethylating agents (Fig. 5). 
DISCUSSION 
B D A P  was reported to be a potent  inhibitor of 
spermine synthase in vitro [15], and the present 
results using several cell lines confirm that it can be 
used to prevent spermine production in mammal ian  
cells. Although the three cell types used in the 
present experiments have very different spermidine 
to spermine ratios, exposure to B D A P  brought 
about a substantial decline in spermine in all of 
them. In fact, the 81)% decline in spermine seen in 
response to B D A P  is consistent with an almost 
complete block at the spermine synthase step. 
Spermine degradation and excretion occur to only a 
very limited extent in these cell cultures so the 
decline in spermine is brought about by the increase 
in cell number  under conditions in which spermine 
synthesis is prevented.  
General  problems with biochemical and phar- 
macological studies using inhibitors include the 
difficulty in establishing the specificity of the effects 
and the possible lack of uptake and /or  stability of 
Table 4. Comparison of BDAP and AdoDATAD in inhibition of spermine synthesis and stimulation of 
AdoMetDC 
Effect on polyamines or AdoMetDC (% of control) 
Cells and treatment Putrescine Spermidine Spermine AdoMetDC 
HT-29 cells, 50/uM BDAP, 48 hr 8 
HT-29 cells, 20 #M AdoDATAD, 48 hr 49 
HT-29 cells, 50 #M BDAP, 72 hr 5 
HT-29 cells, 20/~M AdoDATAD, 72 hr 7(} 
LI210 cells, 50/tM BDAP, 48hr 13 
LI210 cells, 20/~M AdoDATAD, 48 hr 73 
L1210 cells, 50/tM BDAP, 72 hr 76 
LI210 cells, 20/~M AdoDATAD, 72 hr 83 
217 16 410 
226 19 484 
236 18 495 
221 21 382 
141 21 ND* 
16(1 22 N D 
136 15 ND 
128 22 ND 
Results are the means of three separate experiments. The absolute values for control cell polyamines 
are given in Table 1 and for AdoMetDC in Fig. 2. 
* ND, not determined. 
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Fig. 4. Effect of BDAP and spermine on killing of HT-29 
cells by chloroethylating agents. HT-29 cells were treated 
with 50 #M BDAP and/or 5/tM spermine as shown for 
88hr and then exposed to CCNU (upper panel) or 
Clomesone (lower panel) at the concentrations indicated. 
Colony-forming assays were then carried out as described 
under Materials and Methods, and the percentage survival 
was calculated. Results are the means -+ SD for at least 4 
estimations. 
[ ~  Control 
~ -  + BDAP 
(A) +b6G 
80 f +b6G + BDAP 
m 4 0  
~2o f 
o) 




0 100 200 300 400 
Clomesone (laM) 
Fig. 5. Effect of BDAP and O~-benzylguanine on killing 
of HT-29 cells by chloroethylating agents. HT-29 cells were 
treated as shown with 50 #M BDAP for 92 hr and/or with 
25 #M O6-benzylguanine (b6G) for 2 hr and then exposed 
to CCNU (upper panel) or Clomesone (lower panel) at 
the concentrations indicated. Cell killing was then 
determined using the MTT assay. Results are expressed as 
the percentage of cells killed compared with the cells 
treated with no chloroethylating agent. Further details of 
the number of cells plated are given under Materials and 
Methods. Results are the means of at least 4 assays that 
agreed within _+ 5%. 
the inhibitors. Since the structure of BDAP is very 
different from that of the nucleoside spermine 
synthase inhibitor A d o D A T A D  [13] (Fig. 1), the 
two compounds provide a useful pair to evaluate the 
effects of spermine. Both inhibitors are clearly 
superior to other compounds used to block spermine 
production such as dimethyl(5'-adenosyl)sulfonium 
salt [27-29]. The availability of BDAP to complement 
studies with A d o D A T A D  should make it easier to 
establish that effects are due to perturbation of 
polyamine levels. Also, since BDAP is easier to 
synthesize than A d o D A T A D  and is not likely to 
interact with adenosine receptors, it may be more 
suitable for long-term studies in intact animals. 
It should be noted, however, that the results 
shown in Fig. 2 suggest that the induction of 
resistance to BDAP may reduce its effectiveness 
slightly and necessitate higher doses for prolonged 
exposure. The decreased effectiveness of BDAP at 
later time points appears to be due to a diminished 
intracellular level of BDAP but the means by which 
this reduction is brought about are unclear. One 
possibility is the induction of SAT by BDAP followed 
by the acetylation of the compound by this enzyme. 
SAT activity in mammalian cells is normally very 
low but can be increased greatly in response to a 
variety of stimuli including treatment with polyamine 
analogs [20-24]. Although BDAP was much less 
active than BE-3-4-3 as an SAT inducer (Table 3), 
activity was increased. The general structural 
requirement for substrates that can be acetylated by 
SAT is the presence of an aminopropyl group 
attached to another N atom [i.e. H2N(CH2)3NH-R ] 
[21]. BDAP has a suitable structure and is acetylated 
by SAT, albeit at a rate less than I% that of 
spermidine (Pegg AE and Albanese L, unpublished 
observations). In general, acetylation of polyamines 
leads to further degradation and/or excretion from 
the cell [21] so the involvement of SAT in reduction 
of BDAP levels by this mechanism is a plausible 
hypothesis. 
In addition to its effect on spermine levels, 
exposure to BDAP leads to a substantial increase in 
AdoMet DC activity. It is well known that AdoMetDC 
is repressed by both spermidine and spermine 
[30, 34, 35]. The results with BDAP are in agreement 
with this concept. Furthermore, they show that 
spermine is more effective than spermidine in this 
respect, since there was an increase in spermidine 
comparable with the decline in spermine in BDAP- 
treated cells. 
The only major difference between the results of 
exposure to BDAP and to A d o D A T A D  was that 
putrescine levels were much lower in cells exposed 
to BDAP (Table 4). The decline in putrescine in 
response to A d o D A T A D  may be due to the fact 
that spermidine is a better repressor of ODC than 
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spermine and/or to the increase in AdoMetDC 
activity that provides more substrate to convert 
putrescine into spermidine [3, 4, 30, 35, 40]. 
However, this can explain only part of the decline 
in putrescine when BDAP is used since AdoMetDC 
levels increased and ODC levels declined to the 
same extent with both AdoDATAD and BDAP 
(results not shown). The possibility that BDAP and 
putrescine compete for an uptake system and that 
BDAP causes an efflux of putrescine from the cell 
is suggested by these results. 
Depletion of spermine by BDAP had no effect on 
growth in short-term experiments. This is in 
agreement with several other studies showing that 
inhibition of spermine synthesis does not influence 
cell growth [14, 15, 27-30], but it is premature to 
conclude that spermine does not play a vital role in 
mammalian cellular metabolism. As shown in Fig. 
3, longer term exposures may have more marked 
effects, and recent results [17] have shown that 
spermine is more effective than spermidine in 
reversing the cytostatic effects of inhibitors of 
AdoMetDC. This cytostasis does not become 
apparent until 12 days of elimination of AdoMetDC 
activity [17]. 
Although short-term exposures to BDAP had no 
effect on growth, the compound (and other spermine 
synthase inhibitors) may be useful in modifying the 
effects of other agents. First, since spermidine is 
more readily depleted in cells exposed to polyamine 
analogs than spermine, the use of a spermine 
synthase inhibitor may make it easier to deplete 
polyamines in oivo using analogs such as BE-3-4-3. 
However, as shown in Table 1, in cell culture even 
the analogs alone were effective. Second, in HT-29 
tumor cells, exposure to BDAP increased the killing 
by chloroethylating agents. This effect is likely to 
result from an increased level of DNA damage rather 
than a decreased rate of repair since it occurred in 
the presence of O6-benzylguanine, a drug known to 
block repair of the initial DNA lesions that then go 
on to form lethal cross-links [36--39]. The effect of 
BDAP was reversed by spermine, and it is possible 
that the change in spermine levels renders some sites 
in chromatin more available to interact with the 
drugs. This suggests that spermine depletion may be 
useful as treatment with ODC inhibitors [25] in 
increasing the effects of chloroethylating agents. 
However, it should be cautioned that this effect may 
be dependent on the tumor cell type involved. HT- 
29 cells have very high levels of spermine and a high 
spermine:spermidine ratio (Table 1), and this may 
influence their response to such drug combinations. 
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